top of page

Nutreco investment

  • Writer: Shai Ufaz
    Shai Ufaz
  • Jul 3, 2019
  • 1 min read

Nutreco has invested in Israeli startup ViAqua as part of its focus on combatting disease in the aquaculture industry. ViAqua is developing the first orally-administered treatment for shrimp that improves resistance to viral diseases, including White Spot Syndrome Virus (WSSV), and prevents viral epidemics. Nutreco has taken a meaningful minority share that will conditionally grow over time.



 
 
bottom of page